Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01447225
Show Display Options
Rank Status Study
1 Active, not recruiting Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Interventions: Drug: MM-121 (SAR256212) plus Gemcitabine;   Drug: MM-121 (SAR256212) plus Carboplatin;   Drug: MM-121 (SAR256212) plus Pemetrexed;   Drug: MM-121 (SAR256212) plus Cabazitaxel

Indicates status has not been verified in more than two years